The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123064244 12306424 4 F 20121205 20160809 20160426 20160816 EXP CA-JNJFOC-20160422135 JANSSEN 40.31 YR A M Y 60.70000 KG 20160816 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123064244 12306424 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N FKM95012;FKM95011;GAM08011 +MORE 0 LYOPHILIZED POWDER
123064244 12306424 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N FKM95012;FKM95011;GAM08011 +MORE 0 500 MG LYOPHILIZED POWDER
123064244 12306424 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 155 INFUSION N FKM95012;FKM95011;GAM08011 +MORE 0 500 MG LYOPHILIZED POWDER
123064244 12306424 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) INFUSION # 157 TODAY (AT THE TIME OF THIS REPORT) N FKM95012;FKM95011;GAM08011 +MORE 0 500 MG LYOPHILIZED POWDER
123064244 12306424 5 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N FKM95012;FKM95011;GAM08011 +MORE 103772 500 MG LYOPHILIZED POWDER
123064244 12306424 6 SS SOLU-CORTEF HYDROCORTISONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) U 0 200 MG UNSPECIFIED
123064244 12306424 7 SS SOLU-CORTEF HYDROCORTISONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) U 0 200 MG UNSPECIFIED
123064244 12306424 8 C HYDROMORPHONE HYDROMORPHONE 1 Unknown 0 2 MG UNSPECIFIED QID
123064244 12306424 9 C NABILONE NABILONE 1 Unknown 0 1 MG TABLET QD
123064244 12306424 10 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
123064244 12306424 11 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
123064244 12306424 12 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Unknown 0 40 MG UNSPECIFIED
123064244 12306424 13 C GRAVOL DIMENHYDRINATE 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123064244 12306424 1 Crohn's disease
123064244 12306424 2 Crohn's disease
123064244 12306424 3 Crohn's disease
123064244 12306424 4 Crohn's disease
123064244 12306424 5 Crohn's disease
123064244 12306424 6 Premedication
123064244 12306424 7 Premedication
123064244 12306424 13 Premedication

Outcome of event

Event ID CASEID OUTC COD
123064244 12306424 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123064244 12306424 Abdominal pain
123064244 12306424 Fall
123064244 12306424 Infusion related reaction
123064244 12306424 Intestinal resection
123064244 12306424 Ligament sprain
123064244 12306424 Nausea
123064244 12306424 Off label use
123064244 12306424 Product use issue
123064244 12306424 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123064244 12306424 1 20160714 0
123064244 12306424 2 20121205 0
123064244 12306424 3 20160421 0
123064244 12306424 4 20160616 0
123064244 12306424 5 201311 0
123064244 12306424 6 20160714 0
123064244 12306424 7 20160616 0